| Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID) E Pazukhina, M Andreeva, E Spiridonova, P Bobkova, A Shikhaleva, ... BMC medicine 20 (1), 244, 2022 | 100 | 2022 |
| Stop COVID cohort: An observational study of 3480 patients admitted to the Sechenov University Hospital Network in Moscow City for suspected coronavirus disease 2019 (COVID-19 … D Munblit, NA Nekliudov, P Bugaeva, O Blyuss, M Kislova, E Listovskaya, ... Clinical Infectious Diseases 73 (1), 1-11, 2021 | 81 | 2021 |
| Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY T Chatzikonstantinou, L Scarfò, G Karakatsoulis, E Minga, D Chamou, ... EClinicalMedicine 65, 2023 | 6 | 2023 |
| Structure and prognostic signifi cance of 13q14 deletion in chronic lymphocytic leukemia TN Obukhova, MI Kislova, EA Nikitin, MA Kislitsyna, BV Biderman, ... Russian journal of hematology and transfusiology 67 (1), 75-89, 2022 | 5 | 2022 |
| Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia AA Komissarov, M Kislova, IA Molodtsov, AA Petrenko, E Dmitrieva, ... International Journal of Molecular Sciences 24 (1), 416, 2022 | 4 | 2022 |
| COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study ОL Kochneva, M Kislova, EI Zhelnova, AA Petrenko, EA Baryakh, ... Leukemia & Lymphoma 63 (7), 1607-1616, 2022 | 4 | 2022 |
| Структура и прогностическое значение делеции 13q14 при хроническом лимфолейкозе ТН Обухова, МИ Кислова, ЕА Никитин, МА Кислицына, БВ Бидерман, ... Гематология и трансфузиология 67 (1), 75-89, 2022 | 3 | 2022 |
| P654: ibrutinib plus venetoclax in patients with complex karyotype and chronic lymphocytic leukemia A Petrenko, M Kislova, E Dmitrieva, T Novikova, M Kislitsyna, T Obukhova, ... HemaSphere 6, 552-553, 2022 | 2 | 2022 |
| Vaccination in patients with chronic lymphocytic leukemia: current problems MI Kislova, AA Petrenko, MP Kostinov, EA Nikitin Epidemiology and Vaccinal Prevention 20 (3), 91-106, 2021 | 2 | 2021 |
| Significant reduction in the incidence of non‐coronavirus infections in patients with chronic lymphocytic leukemia on ibrutinib and venetoclax treatment during the COVID‐19 … M Kislova, A Petrenko, EA Dmitrieva, A Milenkin, KE Nikitin, VV Ptushkin, ... Hematological Oncology 41 (4), 683-693, 2023 | 1 | 2023 |
| Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias E Nikitin, M Kislova, D Morozov, V Belyakova, A Suvorova, J Sveshnikova, ... Leukemia 37 (7), 1464-1473, 2023 | 1 | 2023 |
| Acalabrutinib in the treatment of chronic lymphocytic leukemia: a review of recent evidence AA Petrenko, MI Kislova, EA Dmitrieva, EA Nikitin Journal of Modern Oncology 23 (2), 332-338, 2021 | 1 | 2021 |
| Вакцинопрофилактика у больных с хроническим лимфолейкозом МИ Кислова, АА Петренко, МП Костинов, ЕА Никитин Эпидемиология и вакцинопрофилактика 20 (3), 91-106, 2021 | 1 | 2021 |
| Complex karyotype is a strong predictor of short-term progression in Chronic lymphocytic leukemia patients treated with ibrutinib T Obukhova, E Nikitin, M Kislitsyna, E Dmitrieva, M Kislova, T Novikova, ... HemaSphere 4 (S1), 293-293, 2020 | 1 | 2020 |
| Venetoclax after Progression on Ibrutinib: Results of a Russian Multicenter Study M Kislova, O Kalashnikova, V Shuvaev, Y Larina, E Pozharsky, T Mitina, ... Blood 142, 6547, 2023 | | 2023 |
| PB1912: BTK AND PLCG2 GENE MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH RESISTANCE TO COVALENT BTK INHIBITOR E Likold, B Biderman, E Dmitrieva, S Smirnova, M Kislova, E Nikitin, ... HemaSphere 7 (S3), e8967737, 2023 | | 2023 |
| S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL ANALYSIS OF THE INTERNATIONAL MULTICENTER STUDY CONDUCTED BY ERIC, IN HARMONY. T Chatzikonstantinou, L Scarfò, G Karakatsoulis, E Minga, D Chamou, ... HemaSphere 7, e24596f8, 2023 | | 2023 |
| Obinutuzumab in combination with chlorambucil in first line treatment of elderly patients with chronic lymphocytic leukemia EE Markova, EA Nikitin, EA Dmitrieva, SY Mayorоva, YB Kochkareva, ... Russian journal of hematology and transfusiology 67 (4), 478-490, 2022 | | 2022 |
| Ibrutinib in combination with rituximab is highly effective in treatment of steroid refractory autoimmune hemolytic anemia E Nikitin, M Kislova, D Morozov, V Belyakova, A Suvorova, J Sveshnikova, ... | | 2022 |
| Акалабрутиниб в терапии хронического лимфолейкоза: обзор актуальных данных АА Петренко, МИ Кислова, ЕА Дмитриева, ЕА Никитин Современная онкология 23 (2), 332-338, 2021 | | 2021 |
Andrii Petrenko在 botkinmoscow.ru 的电子邮件经过验证
